FRI0072 Implementation of Treating Patients to Target in a Long Standing Rheumatoid Patient Population

BackgroundTreating rheumatoid arthritis patients to target (T2T) with a goal of obtaining low disease activity (LDA) or no disease activity (NDA) is an attractive treatment approach and has been shown to result in better outcomes in patients with new onset or relatively recent onset rheumatoid arthritis (RA) [1]. Implementing this strategy in a long standing rheumatology clinic is problematic with a preponderance of RA patients who have chronic diseases including deformities, severe osteoarthritis, and other comorbidities which can lead to confounding results when using traditional DAMs such as the DAS28-CRP. The ultrasound power Doppler joint count (UPDJC) and multiple biomarker disease activity (MBDA) blood test are two new options that may provide additional insights in the assessment of patients with long standing RA.ObjectivesTo implement a T2T strategy in a long-standing rheumatology clinicMethodsAll patients with a diagnosis of rheumatoid arthritis in a long-standing rheumatology clinic underwent evaluation with DAMs including the DAS28CRP, and blood testing with a MBDA (Crescendo). Also, a method for preforming a truncated UPDJC was adopted [2] utilizing a subjective 0 (normal) to 3 (severe) scoring system leading to a possible score of (0-36). The LDA point for the DAS28CRP, MBDA, and UPDJC are